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Abstract
Background: Strict glycaemic control (SGC) has become a contentious issue in modern intensive care.
Physicians and nurses are concerned about the increased workload due to SGC as well as causing harm
through hypoglycaemia. The objective of our study was to evaluate our existing degree of glycaemic
control, and to implement SGC safely in our ICU through a nurse-led implementation of an algorithm for
intensive insulin-therapy.
Methods: The study took place in the adult general intensive care unit (11 beds) of a 44-bed department
of intensive care at a tertiary care university hospital. All patients admitted during the 32 months of the
study were enrolled. We retrospectively analysed all arterial blood glucose (BG) results from samples that
were obtained over a period of 20 months prior to the implementation of SGC. We then introduced an
algorithm for intensive insulin therapy; aiming for arterial blood-glucose at 4.4 – 6.1 mmol/L. Doctors and
nurses were trained in the principles and potential benefits and risks of SGC. Consecutive statistical
analyses of blood samples over a period of 12 months were used to assess performance, provide feedback
and uncover incidences of hypoglycaemia.
Results: Median BG level was 6.6 mmol/L (interquartile range 5.6 to 7.7 mmol/L) during the period prior
to implementation of SGC (494 patients), and fell to 5.9 (IQR 5.1 to 7.0) mmol/L following introduction
of the new algorithm (448 patients). The percentage of BG samples > 8 mmol/L was reduced from 19.2 %
to 13.1 %. Before implementation of SGC, 33 % of samples were between 4.4 to 6.1 mmol/L and 12
patients (2.4 %) had one or more episodes of severe hypoglycaemia (< 2.2 mmol/L). Following
implementation of SGC, 45.8 % of samples were between 4.4 to 6.1 mmol/L and 40 patients (8.9 %) had
one or more episodes of severe hypoglycaemia. Of theses, ten patients died while still hospitalised (all
causes).
Conclusion: The retrospective part of the study indicated ample room for improvement. Through the
implementation of SGC the fraction of samples within the new target range increased from 33% to 45.8%.
There was also a significant increase in severe hypoglycaemic episodes. There continues to be potential
for improved glycaemic control within our ICU. This might be achieved through an improved algorithm
and continued efforts to increase nurses' confidence and skills in achieving SGC.
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Background
Hyperglycaemia, defined as blood glucose > 6.1 mmol/L
[1], and insulin resistance are common in surgical and
critically ill patients. These phenomena occur without pre-
vious diabetes, as a consequence of stress [1,2]. Elevated
blood glucose is related to higher short and long-term
morbidity and mortality rates, dependence on mechanical
ventilation and hospital length of stay [1-5].
Previously, insulin-therapy in our ICU was utilised prima-
rily when blood glucose was persistently above 12 mmol/
L. However, the publication of papers by van den Berghe
[1] describing reduced mortality, morbidity and length of
stay in surgical patients subjected to intensive insulin-
therapy, as well as by Finney [3], demonstrating an asso-
ciation of hyperglycaemia with adverse outcomes in gen-
eral intensive care, led most doctors at our institution to
prescribe insulin to our ICU-patients with a therapeutic
target set at a BG level of 4 to 8 mmol/L. Equipped with a
standard infusion solution of 2 IU/ml of rapidly acting
insulin it was left to nurses to titrate treatment to achieve
these targets. Without any protocol to guide treatment we
became concerned that therapeutic targets were infre-
quently met and that both hyper- and hypoglycaemia
might occur due to lack of commitment from both nurses
and doctors.
van den Berghe and co-workers reported the results of a
study of intensive insulin therapy in medical ICU-patients
[6]. As in their previous study they found that patients
who remained in the ICU for several days profited from
SGC. Also, two studies from mixed ICU settings supported
the notion that both medical and surgical patients may
profit from improved glycaemic control [7,8]. These stud-
ies convinced us that we should both narrow our thera-
peutic target to that of normoglycaemia (4.4 to 6.1 mmol/
L) and implement more rigid guidelines to achieve this
goal.
SGC introduces a risk of severe hypoglycaemia (SHG)
[1,9]. Pittas et al found that ICU-patients treated with
insulin therapy had a threefold risk increase of developing
hypoglycaemia compared with the control group. How-
ever, no adverse outcomes were reported after these inci-
dents [2]. Another study explored the short-term
consequences of SHG in the ICU. Out of 156 patients with
SHG, there were three possible comas or seizures, and no
increase in mortality [10]. On the other hand, in a case-
control study Krinsley et al found severe hypoglycaemia to
be independently associated with mortality in an adult
ICU [11]. The incidence of SHG varies greatly in different
studies with rates from 0.5 to 18.7 % [12]. Two projects
led by nurses reported an 0.9 % incidence of SHG [13,14].
However, it is unclear whether these numbers refer to the
percentage of blood glucose samples or of patients.
Another challenge for ICUs that would like to implement
SGC is the increased workload for nurses: A blood glucose
target of 4.4 to 6.1 mmol/L is a narrow corridor to operate
within [13-16]. This will increase the need for monitoring
and adjustment of insulin and nutrients. Thus, the moti-
vation, acceptance, involvement and commitment of
nurses are of importance for successful implementation of
SGC [13-17]. It is known that to change the behaviour of
a large group demands much more time and effort than
simply passing on new knowledge. It is also important
that those who are responsible are available for discus-
sions and questions during implementation of new proce-
dures [18]. Thus it was decided to assign joint leadership
over this project to two ICU-nurses whose task it would be
to develop and implement an algorithm for SGC in our
ICU. A physician served as reference.
Methods
Ethics
The regional ethics committee waived the need for
informed consent and classified our study as a "quality
improvement" project. Permission for data collection was
deferred to the hospital's data inspector who formally
approved the study.
Setting
Our hospital has a 44-bed department of mixed medical
and surgical intensive care on a single floor. This study
was limited to the 11-bed section of general intensive care
for adults (the other three sections being paediatric, cardi-
othoracic surgical and general postoperative). The ICU
attends to several national functions. The majority of
patients in the section described are admitted after neuro-
surgery, abdominal- and bone marrow transplants, as well
as with complications following acute cardiac conditions
and other medical disease. The nurse: patient ratio is 1:1.
The patients surveyed had a median age of 56 years, stayed
for a median of 2.0 days, and were mechanically venti-
lated 77.6 % of the time.
Risk scoring was performed upon discharge or death using
simplified acute physiology score II (SAPS II) with data
obtained during the first 24 hours after admission. Only
patients who either died in the ICU during the first 24
hours or had LOS > 24 hours were scored (Table 1).
Design
This was a combined retrospective analysis and prospec-
tive evaluation of glucose control in a single ICU with the
purpose of implementing SGC in a safe manner.
In the retrospective part of the study (2004 – 2005) we
mapped existing conditions regarding blood glucose reg-
ulation in our ICU. Because glycaemic control was already
an issue, with BG limits set between 4–8 mmol/L, virtu-BMC Nursing 2008, 7:1 http://www.biomedcentral.com/1472-6955/7/1
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ally all patients in the retrospective dataset received insu-
lin (for data on insulin consumption, see "costs" in
Results section). Data were retrieved from the laboratory
database at the Department of clinical biochemistry. We
analysed BG values from 15009 samples from 494
patients obtained during the 20 months before introduc-
tion of the algorithm, constituting a mean of 750 samples
per month.
The prospective study (2006) included six steps to safely
implement SGC:
1. To obtain nurse commitment and a sense of "owner-
ship" in the project, two nurses (KAK and EMB) were
given daily leadership for the implementation of SGC. A
physician (JHL) served as reference.
2. A blood glucose algorithm was developed (Fig 1). This
was based on the Leuven- protocol [1], and adapted
through discussions between ICU nurses and ICU physi-
cians. Experiences from other ICUs in Norway were con-
sidered in the discussions. It was imperative that the
algorithm should be easy to use and in pocketsize format.
A graphic designer was consulted in designing the algo-
rithm.
3. Lectures were provided for all physicians and nurses in
the ICU. These lectures focussed both on original research
on SGC, statistical results from our retrospective study
and information about the algorithm.
4. Key literature was made easily accessible in the ICU.
5. Blood glucose statistics were analysed consecutively to
assess performance and uncover incidences of hypogly-
caemia. We analysed BG values from 24459 samples
obtained from 448 patients over 12 months (2038 sam-
ples per month).
6. Feedback to nurses and doctors in the form of posters
with simple descriptive statistics illustrated by coloured
graphics were suspended on the main door to the rest area
the ICU (Fig 2). Periodic summaries were e-mailed to the
ICU staff. These analyses also functioned as a safety check
Example of feedback to ICU-nurses Figure 2
Example of feedback to ICU-nurses. Descriptive statistics 
were    presented on posters in the ICU and in e-mails to 
individual nurses.
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Table 1: Patient charcteristics
2004–5 2006
N4 9 4 4 4 8
Age [IQR]* 56 [39–64] 55 [42–66]
Male Sex (%) 53.4 58.4
LOS [IQR]* 2.0 [0.7–6.4] 1.9 [0.8–5.8]
LOS > 72 h, n (%) 210 (42.5) 206 (46.0)
SAPS II [IQR]* 42 [28–54] 40 [30–54]
SAPS II completeness, n (%)‡ 329 (67) 259 (58)
*) Age, LOS and SAPS II are given as median values [interquartile 
range].
‡) Frequency (%) of patients who received a SAPS II score. Eligible 
patients either died < 24 hours after admission or had LOS > 24 hours.
Glucose-infusion algorithm used in the study Figure 1
Glucose-infusion algorithm used in the study.
Rikshospitalet
Universitetsklinikk © Rikshospitalet Medical Centre
>11.1 mmol/L
11,1 - 6,1 mmol/L
<6,1 mmol/L
Start insulin at 2-4 U/hr
Start insulin at 1-2 U/hr
Do not start insulin
Sudden decrease 
(>50%)
3,3 - 4,4 mol/L
Halve the Insulin dose
Reduce Insulin dose
Stop Insulin, check glucose infusion 
lines, pumps and bags
MEASURE BG WITHIN ONE HOUR
2,2-3,3 mmol/L
<2,2 mmol/L
Close to target?
4,4 - 6,1 mmol/L
MEASURE BG EVERY 4TH HOUR
Adjust Insulin by 0.2 – 0.6 U/hr
No action
MEASURE BG EVERY 1 – 2 HOUR, 
UNTIL 4.4 – 6.1 MMOL/L
Increase Insulin by 1 – 2 U/hr
6,1 - 7,8 mmol/L
>7,8 mmol/L
Increase Insulin by 0.4 – 1 U/hr
BLOOD GLUCOSE (BG) ON ARRIVAL IN ICU ALGORITHM FOR STRICT GLUCOSE 
CONTROL
• Consult physician if BG >20 mmol/L or <2.2 mmol/L   
   or if you have to divert from the algorithm
• Beware fluctuations in insulin demands as patient                         
   medical status improves or deteriorates.
• Stop Insulin when nutrition is interrupted (e.g. 
    tracheotomy, CAT-scan etc)
• Beware medications that may affect your             
   patients BG, e.g. beta-blockers, steroids, ACE- 
   inhibitors and thyroid hormones.
• BG   11mmol/L without insulin is accepted when     
   admitting your patient to the ward.
This is a guide; Insulin administration must always be 
guided by common sense and adjusted according 
to the patients individual condition.
Stop Insulin, check glucose lines, 
pumps and bags. Give bolus of 20 ml 
glucose 50% (500mg/ml). Check BG 
and repeat bolus as needed.BMC Nursing 2008, 7:1 http://www.biomedcentral.com/1472-6955/7/1
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for the project group as incidents of hypoglycaemia were
quickly identified. The project nurses gave individual bed-
side feedback to the ICU nurses, and they were available
for discussions and questions.
Nutrition and insulin
Physicians in the ICU ordered nutrients and insulin per
respective algorithms (see below). Glucose infusion was
initiated at admission to ICU (normally 100 g per day in
adults) and was usually discontinued when mixed enteral
or parenteral nutrition commenced. Patients were fed
according to our nutritional support algorithm [19]: This
requires physicians to set a feeding target (normally
25–35 kcal/kg/day) and allows for use of standard mix-
tures of enteral and/or parenteral nutrition depending on
gastrointestinal function (energy composition protein/
amino acids ~15 %, fat/lipids ~35 %, carbohydrates/glu-
cose ~50 %). With this algorithm 75% of our patients
receives mixed nutritional support, including 150–300 g
glucose, during the first day after admission, although full
caloric support may not be achieved for several days [19].
Rapidly acting insulin (2 U/ml) was administered intrave-
nously as a continuous infusion as described in the algo-
rithm (Fig 1). The goal of the insulin treatment was to
normalise high levels of BG as soon as possible or to
maintain normoglycaemia. Virtually all patients received
insulin. The hospital pharmacy provided information on
yearly consumption of insulin by our ICU (see "costs" in
Results section).
Analysis
All patients admitted during the study period were
included, regardless of length of stay and unless a physi-
cian specifically gave a written order that SGC was not to
be initiated. The blood glucose measurements were arte-
rial whole blood samples. We used four different blood
gas analysers (Radiometer Copenhagen ABL 700) located
in the ICU, which are regularly calibrated against a refer-
ence instrument at the Department of Clinical Biochemis-
try. The results of these analyses are automatically
registered at the central laboratory database. Statistical
analysis was performed with Statistical Package of Social
Sciences (SPSS), version 13. For analysis of blood-glucose
values we used both non-parametric statistics (Mann-
Whitney's test) as well as "mixed model analysis" in
which pre- and post implementation periods and length
of stay in the ICU were treated as fixed factors and individ-
ual patients as random factors. Proportions were analysed
with Chi-Square with Yates' correction.
Costs
We calculated the incremental costs of insulin, an
increased number of blood-gas analyses (syringes, chemi-
cals), but excluding staff-expenditures (since manpower
was not increased) as well as loss due to depreciation.
Results
Retrospective analysis (2004–5)
The retrospective analysis served as a reference to existing
conditions, allowing us to evaluate the effect of the imple-
mentation of SGC. We obtained 15009 BG samples from
494 patients of whom 210 had a length of stay (LOS) in
excess of 72 hours (Table 1). The median BG level was 6.6
mmol/L [IQR 5.6–7.7] (Table 2); 77.5 % of the BG meas-
urements were within the then existing limits of 4–8
mmol/L and 33% of samples were within the "optimal"
range of SGC, i.e. 4.4 to 6.1 mmol/L. Fourteen samples
(0.1 %) from twelve patients (2.8 %) were defined as
severely hypoglycaemic (< 2.2 mmol/L) (Table 3). Of
these, two patients died while hospitalised at our institu-
tion and by 2007, 5 deaths were registered (all causes,
Table 3). The median time interval from the first hypogly-
caemic episode till death was 9 days. Hypoglycaemic
patients had a median SAPS II score of 54 (mean score 55)
while those hypoglycaemic patients who died had a
median SAPS II score of 61 (mean score 60). We did not
assess our patients for minor brain dysfunction after
hypoglycaemia.
Introduction of strict glycaemic control (2006)
Following lectures, dissemination of literature and the
new algorithm at the end of 2005, strict glycaemic control
was swiftly introduced at the beginning of 2006 and met
Table 2: Median arterial blood glucose
All samples
median (IQR)
≤12 hours in ICU
median (IQR)
> 12 hours in ICU
median (IQR)
Before algorithm (2004–5) 6.6 (5.6 – 7.7)
n = 15009
7.1 (5.9 – 8.8)
n = 1591
6.5 (5.6 – 7.6)
n = 13418
After algorithm (2006) 5.9 (5.1 – 7.0)
n = 24459
6.9 (5.4 – 8.6)
n = 2928
5.9 (5.0 – 6.8)
n = 21531
Median blood glucose values (IQR = interquartile range) of all samples obtained before and after implementation of an algorithm of strict glycaemic 
control. Differences between pre- and post algorithm values were significant for all subsets (Mann-Whitney's test). Mean blood glucose values in 
2004–5 and 2006 were 6.82 and 6.25 mmol/L, respectively (mean difference 0.58 mmol/L, 95% confidence interval 0.54 to 0.62; p < 0.001; "mixed 
model analysis").BMC Nursing 2008, 7:1 http://www.biomedcentral.com/1472-6955/7/1
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with little opposition. Only a handful of patients were
deemed unsuitable for SGC by the attending physician
(pancreas transplant recipients with their own BG
regime), and our nurses enthusiastically embraced this
therapy. Feedback regarding the algorithm was mainly
positive. The nurses liked the design, and found it easy to
understand and follow. The pocket size was appreciated.
Inexperienced nurses tended to embrace it to a larger
extent than experienced nurses. Nevertheless, some con-
cern was raised about the algorithm, which did not pre-
vent all hypoglycaemias (Table 3, see Additional file 1).
This was evident especially where the BG level was declin-
ing rapidly, but due to the frequent measurements, fell
outside the definition of 50 % decrease and was therefore
not identified as a potential threat. In our experience, 4
hours between each sample when the previous test was
within the normal limit, proved to be too long.
Feedback and bedside follow-up
Posters with statistics and graphs received mixed interest.
Due to technical reasons beyond our control the collec-
tion of data was in periods impeded, and this caused feed-
back to be less regular than we would have preferred. On
the other hand periodic e-mails with similar content but
also with comments on performance generated construc-
tive discussions among the ICU staff as well as between
the ICU staff and the project group. Also, bedside follow-
up by the project nurses to guide colleagues in how to use
the algorithm proved to be helpful.
Glycaemic control
Following introduction of SGC we obtained 24459 BG
samples from 448 patients, of whom 206 had LOS > 72
hours (Table 1). The median BG level was 5.9 mmol/L
[IQR 5.1–7.0]. Thus, the difference before and after imple-
mentation of SGC was 0.7 mmol and highly significant (p
< 00.1, Table 2). Glycaemic control improved with length
of stay in the ICU and was consistent after approximately
12 hours following ICU admission (Fig 3). We found that
80.9 % of the samples were within the previously defined
limits of 4–8 mmol/L, while samples within the narrower
range of 4.4–6.1 mmol/l had increased from 33 % in
2004–5 to 45.9 % in 2006, a relative increase of 39 % (Fig
4). The fraction of normoglycaemic samples improved
with length of stay and the frequency of hyperglycaemic
samples (> 8 mmol/L) fell from 19.2 % to 13.1 %, a rela-
tive decrease of 32 %. There was an increase in the inci-
dence of severe hypoglycaemia; 40 patients (8.9 %)
experienced one or more episodes of BG < 2.2 mmol/L
Boxplots represent median, quartiles, and extreme values of  p-glucose samples [mmol/L] as a function of length of stay  and year of admittance Figure 3
Boxplots represent median, quartiles, and extreme values of 
p-glucose samples [mmol/L] as a function of length of stay 
and year of admittance.
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Table 3: Hypoglycaemia (arterial blood glucose < 2.2 mmol/L)
2004 – 5 2006
Frequency of samples, n/N (%)1 14/15009 (0.09) 62/24459 (0.25)
Frequency of patients, n/N (%)1 12/494 (2.4) 40/448 (8.9)
Arterial blood glucose 2 1.8 mmol/L (1.3 – 2.1) 1.8 mmol/L (0.9 – 2.1)
30-day mortality (%) 3 3/12 (25) 12/40 (30)
Interval till death (days) 4 9 (0 – 533) 4 (0 – 53)
SAPS II score (deceased vs. survivors) 5 61 (39 – 86) vs 54 (26 – 75) 53 (31 – 96) vs 33 (15 – 60)
Footnotes:
1. P < 0.001 (Chi Square)
2. Median (range) of blood glucose values < 2.2 mmol/L
3. 30-day mortality among hypoglycaemic patients. In-hospital mortality was 2/12 (17%) vs. (10/40 (25 %), not significant.
4. Median number of days from first hypoglycaemic episode till time of death (range)
5. Median SAPS II score (range) of hypoglycaemic patients who died vs. patients who survivedBMC Nursing 2008, 7:1 http://www.biomedcentral.com/1472-6955/7/1
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(62 samples, 0.25 %). Of these, 10 patients died while
hospitalised at our institution (25 %) and by 2007, 15
deaths were registered (all causes, Table 3, Additional file
1). The median time interval from the first hypoglycaemic
episode till death was 4 days. Most hypoglycaemic inci-
dents occurred during the first days after admission (Fig
5). Hypoglycaemic patients had a median SAPS II score of
39 (mean score 45) while those hypoglycaemic patients
who died had a median SAPS II score of 53 (mean score
60). We did not assess our patients for minor brain dys-
function after hypoglycaemia.
Effect on mortality was not formally assessed. However, in
2004–5 and 2006 ICU-mortality was 17.5 % and 13.8 %,
respectively (all admissions). For patients who remained
in the ICU for more than 24 hours or died within the first
24 hours after admission, ICU- and 30-day mortality was
24.9 % and 32.6 % in 2004–5. In 2006 ICU- and 30-day
mortality was 19.7 % and 28.6 %. The median SAPS II
scores in 2005 and 2006 were 42 and 40, respectively
(Table 1).
Costs
The workload expanded from 750 blood-gas samples per
month to 2038 samples per month. Insulin consumption
was 303 000 IU per year in 2004, 379 000 IU per year in
2005 and 415 000 IU per year in 2006. This led to an
increase in material costs (insulin, syringes, chemicals),
from € 1561/month to € 3550/month, equating a 127 %
rise in expenses, not considering personnel costs (since
manpower was not increased) and loss due to deprecia-
tion.
Discussion
Responses to the introduction of SGC
Both education and the possibility to discuss experiences
have been pointed out as success-criteria when imple-
menting new protocols [13]. When teaching the ICU staff
about the principles and practice of SGC, the main focus
was on practicalities for the nurses and the benefits for the
patients. During these sessions discussion was encour-
aged. We received few objections to the increased work-
load. The 1:1 nurse: patient ratio in our ICU may have
contributed to the positive attitude. The staff already had
experience in managing insulin infusions, albeit less
strictly, when the BG target range was 4 to 8 mmol/L. The
main reactions from both the nursing staff and physicians
were interest, support and satisfaction. Such positive
responses are described in the literature to be related to
understanding the protocols rationale and benefits
[13,20]. With very few exceptions doctors prescribed BG
targets according to the new algorithm. From time to time
it was necessary to curb enthusiasm from wards that
wanted to participate in the study, and physicians who
wanted to use the algorithm outside the ICU.
Written feedback
Contrary to our expectations, posters with performance
statistics generated little interest. On the other hand, e-
mails with the same information caused discussions and
proved valuable. It seems that e-mails allowed our co-
workers to assess the feedback at their own pace and when
it did not interfere with other obligations. We find this
Hypoglycaemic episodes (BG < 2.2 mmol/L) plotted against  length of stay. Reference lines are placed at 12 and 72 hours Figure 5
Hypoglycaemic episodes (BG < 2.2 mmol/L) plotted against 
length of stay. Reference lines are placed at 12 and 72 hours. 
Twenty-two episodes that occurred > one week after admis-
sion to ICU have been omitted from the figure.
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experience useful with respect to future quality enhance-
ment projects.
Glycaemic control
During 2004–5, 77.5 % of blood-glucose samples were
within the target-range specified at that time, i.e. 4–8
mmol/L. The number of cases of severe hypoglycaemias
was low. Thus, nurses were able to reach set targets even
with no algorithm to guide therapy. The statistics indicate
that nurses conservatively preferred to keep the BG levels
in the higher end of the target range. This finding was con-
firmed in discussions with the nurses. The nurses' ration-
ale was to avoid SHG. Several experienced nurses
expressed uncertainty with the use of an algorithm to con-
trol the BG level instead of the 'good old way' of intuition
and experience. However, following introduction of new
therapeutic targets, an algorithm to guide therapy and
extensive teaching and feedback, glycaemic control
improved significantly, albeit at the cost of increased
expenditure and more frequent hypoglycaemia. Was the
reduction in median BG from 6.6 mmol/L to 5.9 mmol/L
important enough to justify these risks? It is evident from
Figs 3 and 4 that a downward shift of all BG values was the
result of our project. Thus, the frequency of samples with
BG > 8 mmol/L was reduced by 32 %. Finney et al found
a strong association between higher level of BG and risk of
death and suggested an upper tolerance limit of 8 mmol/
L [3]. We are convinced that this can not be achieved
unless one aims for a narrower range, i.e. normoglycae-
mia.
The studies by van den Berghe et al. [1,6] indicated that
primarily patients who remained in the ICU for several
days profited from SGC. This has resulted in suggestions
that SGC be withheld until patients have remained in the
ICU for three days. In our study 210 and 206 patients had
LOS > 3 days in the periods before and after implementa-
tion of SGC, i.e. 44 %. Does this mean that the remaining
patients were exposed to an unnecessary risk? Our inter-
pretation of the results of the randomised trials is that any
benefit of SGC accumulates with increasing LOS. As it is
extremely difficult to predict LOS for patients who are
admitted to the ICU, we believe it to be a sensible strategy
to initiate SGC as early as possible. Routines must be
developed, however, to avoid hypoglycaemia (see below).
Glycaemic control improved for the majority of our
patients. These results may be partially explained by the
bedside follow-up and continuous attention to the ration-
ale for SGC by the project-nurses. Also, the 1:1 nurse:
patient ratio ensured that nurses attended to only one
patient at a time. Furthermore, almost all our ICU patients
were fed using enteral nutrition, possibly another contrib-
uting factor to achieving SGC [17]. Our continued goal is
that our nurses become comfortable with BG levels in the
middle range of normal, thus avoiding hyperglycaemia
that would otherwise occur because they are "playing it
safe".
Hypoglycaemia
The number of patients who experienced severe hypogly-
caemia increased from 12 (2.4 %) to 40 (8.9 %) following
implementation of SGC. This compares well with pub-
lished results [1,6,12] but is nevertheless a cause for con-
cern. It is difficult to establish causality, if any, between
episodes of hypoglycaemia and subsequent deaths and to
avoid bias we have consulted with independent expert
who is now evaluating the cause of death in patients who
were hypoglycaemic. The death rate among hypoglycae-
mic patients did not exceed expected mortality rate as
assessed by SAPS II score. Also, patients who died after
hypoglycaemia were at higher baseline risk of death than
survivors (Table 3, Additional file 1). In a recent review,
Cryer refers to laboratory work in non-human primates
that demonstrated a need for prolonged (i.e. several
hours) of severe hypoglycaemia (< 1.0 mmol/L) to relia-
bly produce brain damage [21]. The situation may well be
different in critically ill patients, in particular those whose
metabolic demands are only marginally met due to their
illness [11]. On the other hand, hyperglycaemia has con-
sistently been shown to be associated with severity of
brain damage in head injured patients or those with
anoxic coma [22,23]. Kanji et al (2004) claims that to
eliminate the incidence of hypoglycaemia completely is
unrealistic since ICU patients have significant fluctuations
in metabolic and endocrine demands [16].
Although mortality was not formally assessed, ICU- and
30-day mortality in 2005 and 2006 do not raise cause for
alarm.
Need for algorithm revision?
The hypoglycaemias that resulted from the introduction
of our algorithm led to a suggestion that unless BG was
truly stable, no more than two hours should pass between
blood-glucose measurements. If uncertain, or with
changes in the patients condition, nurses were encouraged
to measure the BG even more frequent. Also, nurses were
encouraged to compare their own assessment, based on
experience, with the algorithm. Thus, the status of the
algorithm changed from "binding" to "guiding". Most
hypoglycaemic episodes occurred early after admission to
our ICU (Fig 5). This may indicate that insufficient atten-
tion was given to the issues of nutrition and glycaemic
control in the early phase when patients were being stabi-
lised in the ICU. Also, our algorithm may be criticised
because it contains some subjective language and there-
fore requires interpretation by experienced nurses. This
could potentially represent a problem for new nurses in
training. However, new nurses in our ICU always workBMC Nursing 2008, 7:1 http://www.biomedcentral.com/1472-6955/7/1
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together with an experienced coach and it is therefore
unlikely that hypoglycaemia occurred as a result of errors
made by inexperienced nurses.
On the other hand our algorithm is not dose defining and
allows for some variability in how aggressively nurses may
treat blood-glucose aberrations. A number of different
protocols used achieve SGC were reviewed by Meijering et
al who concluded that dynamic scale protocols, similar to
ours, yielded the best results [17]. More recently pub-
lished protocols are often dose defining and computer
guided, and claim superiority over less rigorous protocols,
such as ours, particularly with respect to avoiding
hypoglycaemia. However, the numbers of patients
included in many of these most recent studies are often
small, typically ranging from twenty or less [14,24-27] to
50–60 patients [28-30] (but see below). In our study only
a small fraction of blood samples were hypoglycaemic
(0.25 %), but this nevertheless affected 8.9 % of patients
following introduction of SGC (Table 3). This may indi-
cate that a fairly large number of patients should be
included before superiority of any particular protocol is
claimed.
A good example of a dose defining insulin infusion proto-
col was recently published by Braithwaite et al. who
reported the results in 24 trauma patients [31]. The proto-
col was arranged as a table with six columns containing
detailed instructions on insulin infusion rates depending
on BG. The patient was assigned a particular treatment
column depending on his or her response to therapy. BG
was controlled hourly until stable and thereafter every 2
hours. Target (blood-glucose < 6.1 mmol/L) was reached
at a median time of 11 hours and BG thereafter fluctuated
very little. The authors observed no cases of severe
hypoglycaemia. If similar safety and efficacy can be dem-
onstrated in a large patient sample this protocol is an
attractive alternative to our algorithm, especially because
it lends itself to computerization.
Thomas et al used a web-based insulin dose calculator to
achieve tight glycaemic control in a 16-bed ICU [32]. A
total of 601 patients were subjected to this protocol,
which was amended after 502 patients to allow for a
higher insulin dose. Only 19 episodes of severe hypoglyc-
amia were noted throughout this implementation (3.1
%), but the frequency seemed to increase after the amend-
ment. Also, Davidson and coworkers reported experiences
with a computer-directed intravenous insulin system that
resulted in rapid glycaemic control and a low incidence
(2.6 %) of hypoglycaemia in a large patient cohort [33].
These authors contrast the use of a computer-directed sys-
tem with that of van den Berghe [1], which depends on
trained nurses. However, in a smaller study Shulman et al
reported that computerised decision-supported intensive
insulin therapy did not result in tight glycaemic control
and that 10 % of patients became hypoglycaemic [30]. To
us it seems only reasonable that nurse-commitment and
skill will contribute to success in obtaining glycaemic con-
trol in the ICU, whether they are assisted by computerised
protocols or not.
Conclusion
A nurse-led implementation of an algorithm for strict gly-
caemic control was well received by the staff in our ICU.
The data showed significant improvement in the regula-
tion of BG in our patients, but there was an increase in
cases of severe hypoglycaemia indicating a need for algo-
rithm revision. We will continue to encourage nurses to
feel confident in working to obtain normoglycaemia by
focussing on the benefits and rationale of strict glycaemic
control.
Key messages
￿ To achieve strict glycaemic control in our ICU we
selected two nurses to lead the implementation of a new
insulin infusion algorithm
￿ All nurses in our ICU underwent training to obtain
knowledge about the benefits and potential dangers of
strict glycaemic control Nurses' confidence in using an
insulin infusion algorithm was strengthened through
daily feedback at the bedside and weekly statistics and
graphs describing results
￿ This strategy led to a significant improvement in glycae-
mic control in our ICU, but also increased the number of
patients who had an hypoglycaemic episode and high-
lighted a need for protocol revision
￿ Involving nurses in the implementation of new thera-
pies results in commitment, confidence and a "sense of
ownership" that improves performance
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